ALFA Finder| Margins | Targeting 15.5% to 18% EBITDA margins across different business segments. |
|---|---|
| Order book | Good order book reported in Prague nutraceutical venture. |
| Demand visibility | Steady inquiries and consistent demand across key product categories and geographies. |
| Management confidence | High optimism for FY27 across all three business verticals. |
Growth
Q4 Consolidated Revenue ₹132.1M; PAT ₹5.5M (3.97% margin). Standalone Revenue ₹105.1M; EBITDA ₹16.58M (14.7% margin).
Outlook
FY27 guidance: Base business ₹80-85cr, Pune IVF plant ₹60-65cr. Targeted EBITDA margins 15.5-16.5% (base) and 17-18% (IVF).
Risks
Geopolitical tensions in Middle East disrupted March exports; rising raw material (API/packaging) and logistics costs.
Earnings Call filed with BSE, NSE: SANJIVIN. Summary written with AI assistance from the document.
Sanjivani Paranteral Ltd: key numbers
- Share price
- ₹178.55
- Market cap
- ₹219.3 Cr
- Revenue (annual)
- ₹68.67 Cr
- Net profit (annual)
- ₹6.79 Cr
- P/E (TTM)
- 24.5×Sector 43.8×
- Promoter holding
- 31.56%+0.00% QoQ
- FII holding
- 0.00%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Sanjivani Paranteral Ltd
All →Sanjivani Paranteral Convertible Warrants
Sanjivani Paranteral received BSE in-principle approval for issuing 5,00,000 warrants to the promoter on a preferential basis, at not less than Rs 147.39 each. Listing is not yet approved and will follow allotment.
- Value
- ₹7.37 Cr
Sanjivani Paranteral Q2 FY27 Results: Net Profit ₹4.1 Cr, Up 156.2% YoY
Sanjivani Paranteral Ltd reported revenue from operations of ₹25.3 Cr (+63.2% YoY) and net profit of ₹4.1 Cr (+156.2% YoY) for Q2 FY27.
- Key figure
- Net profit ₹4.1 Cr · +156.2% YoY
Sanjivani Paranteral Board Meeting Date
Sanjivani Paranteral will hold a board meeting on 5 November 2026 to approve Q2 unaudited results. The agenda is only proposed until the meeting is held.
Sanjivani Paranteral Other Announcement
Sanjivani Paranteral Ltd has submitted its quarterly shareholding pattern for the period ended September 30, 2026, as required under SEBI listing regulations.
Sanjivani Paranteral Fund Raise
Sanjivani Paranteral clarified the objects of its proposed 5 lakh convertible warrant issue to BSE. Proceeds of ~₹5.80 Cr will fund capex and subsidiary working capital for expansion.
Sanjivani Paranteral Annual General Meeting
Sanjivani Paranteral Limited held its 32nd Annual General Meeting on September 16, 2026. The meeting concluded with resolutions on financial statements and director re-appointment.